A group including First Avenue CEO Dayna Frank has purchased the downtown Minneapolis property containing the Fine Line music venue. The purchase was led by JoAnna Hicks of Element Commercial Real ...
A bill moving through the California Legislature would test students as early as kindergarten on math. It's part of an effort ...
Please provide your email address to receive an email when new articles are posted on . Sacituzumab govitecan-hziy is approved for adults with triple-negative breast cancer across PD-L1 status. The ...
The survival outlook for patients with HER2-positive metastatic breast cancer has changed significantly for the better over the last two decades. For example, a European cohort study showed that ...
Mayfair Gold Corp ("Mayfair", "Mayfair Gold", or the "Company") (TSXV:MFG, AMEX:MINE) is pleased to announce final results and evaluation of the tight-spaced Grade Control ("GC") drilling program.
TORONTO, June 18, 2026 /CNW/ - Mayfair Gold Corp. ("Mayfair", "Mayfair Gold", or the "Company") (TSXV: MFG) (NYSE American: MINE) is pleased to announce final results and evaluation of the ...
The Nation’s Report Card released Wednesday revealed that a larger percentage of 9-year-old students were performing at or above “Level 200” for both reading math than students that were the same age ...
Datopotamab deruxtecan is now a first-line targeted therapy for immunotherapy-ineligible metastatic TNBC, addressing the ~70% lacking actionable PD-L1 eligibility and historically limited to ...
As students move up through the grades in elementary and middle school, math marches relentlessly forward—whether they’re ready or not. Math is a hierarchical field, building sequentially on prior ...
The Vertical Energy Centre (VEC) has been upgraded with automated manufacturing processes designed to support certification and production. Source (All Images) | Vertical Aerospace Vertical ...
In this segment, Dr. Gregory Vidal outlines what a typical first-line treatment plan looks like for patients with ER-positive, HER2-negative metastatic breast cancer. In this segment, Dr. Gregory ...
Primary endpoint met in first randomized Phase 2 study, FOURLIGHT-1, showing a 40% reduction in the risk of disease progression or death with manageable safety profile More than 90% of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results